Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...

Cancer of the prostate has become the leading cause of cancer diagnoses among males in the United Kingdom. Its treatment, ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...

The marathon surgical session, conducted between 8 am and 5 pm, was led by Dr (prof) Santosh Kumar, with the procedures ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

I was one in eight. One in eight men will be diagnosed with prostate cancer in their lifetime. Nah, I was one in six. One in ...

Trethera Corp. received a $2.7M NIH grant to study combining TRE-515 with KRAS inhibitors for lung cancer. Learn how this ...

Philip Duncombe was just 52 when he was diagnosed with prostate cancer but a medical trial gave him and wife Sue eight months ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with ...

The creator of the 1970s TV programme Tiswas urged people to donate to Cancer Research UK. The 82-year-old from Ombersley, ...

The Phase 3 AMPLITUDE trial led by UCL found that adding the PARP inhibitor niraparib to standard hormone therapy may slow ...